Biosimilar Monoclonal Antibodies Market - Global Outlook and Forecast 2021-2027
Report Code: KNJ777350 No. of Pages: 90 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Biosimilar Monoclonal Antibodies in global, including the following market information:
Global Biosimilar Monoclonal Antibodies Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Biosimilar Monoclonal Antibodies Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Biosimilar Monoclonal Antibodies companies in 2020 (%)
The global Biosimilar Monoclonal Antibodies market was valued at 6114.7 million in 2020 and is projected to reach US$ 15660 million by 2027, at a CAGR of 26.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biosimilar Monoclonal Antibodies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilar Monoclonal Antibodies Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Biosimilar Monoclonal Antibodies Market Segment Percentages, By Type, 2020 (%)
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
Global Biosimilar Monoclonal Antibodies Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Biosimilar Monoclonal Antibodies Market Segment Percentages, By Application, 2020 (%)
Oncology
Autoimmune Disease
Other
Global Biosimilar Monoclonal Antibodies Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Biosimilar Monoclonal Antibodies Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilar Monoclonal Antibodies revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Biosimilar Monoclonal Antibodies revenues share in global market, 2020 (%)
Key companies Biosimilar Monoclonal Antibodies sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Biosimilar Monoclonal Antibodies sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy’s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals
1 Introduction to Research & Analysis Reports
1.1 Biosimilar Monoclonal Antibodies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Monoclonal Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Monoclonal Antibodies Overall Market Size
2.1 Global Biosimilar Monoclonal Antibodies Market Size: 2021 VS 2027
2.2 Global Biosimilar Monoclonal Antibodies Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Biosimilar Monoclonal Antibodies Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Biosimilar Monoclonal Antibodies Players in Global Market
3.2 Top Global Biosimilar Monoclonal Antibodies Companies Ranked by Revenue
3.3 Global Biosimilar Monoclonal Antibodies Revenue by Companies
3.4 Global Biosimilar Monoclonal Antibodies Sales by Companies
3.5 Global Biosimilar Monoclonal Antibodies Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Biosimilar Monoclonal Antibodies Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Biosimilar Monoclonal Antibodies Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilar Monoclonal Antibodies Players in Global Market
3.8.1 List of Global Tier 1 Biosimilar Monoclonal Antibodies Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilar Monoclonal Antibodies Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilar Monoclonal Antibodies Market Size Markets, 2021 & 2027
4.1.2 Infliximab
4.1.3 Rituximab
4.1.4 Trastuzumab
4.1.5 Adalimumab
4.1.6 Other
4.2 By Type - Global Biosimilar Monoclonal Antibodies Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Monoclonal Antibodies Revenue, 2016-2021
4.2.2 By Type - Global Biosimilar Monoclonal Antibodies Revenue, 2022-2027
4.2.3 By Type - Global Biosimilar Monoclonal Antibodies Revenue Market Share, 2016-2027
4.3 By Type - Global Biosimilar Monoclonal Antibodies Sales & Forecasts
4.3.1 By Type - Global Biosimilar Monoclonal Antibodies Sales, 2016-2021
4.3.2 By Type - Global Biosimilar Monoclonal Antibodies Sales, 2022-2027
4.3.3 By Type - Global Biosimilar Monoclonal Antibodies Sales Market Share, 2016-2027
4.4 By Type - Global Biosimilar Monoclonal Antibodies Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Monoclonal Antibodies Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Autoimmune Disease
5.1.4 Other
5.2 By Application - Global Biosimilar Monoclonal Antibodies Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Monoclonal Antibodies Revenue, 2016-2021
5.2.2 By Application - Global Biosimilar Monoclonal Antibodies Revenue, 2022-2027
5.2.3 By Application - Global Biosimilar Monoclonal Antibodies Revenue Market Share, 2016-2027
5.3 By Application - Global Biosimilar Monoclonal Antibodies Sales & Forecasts
5.3.1 By Application - Global Biosimilar Monoclonal Antibodies Sales, 2016-2021
5.3.2 By Application - Global Biosimilar Monoclonal Antibodies Sales, 2022-2027
5.3.3 By Application - Global Biosimilar Monoclonal Antibodies Sales Market Share, 2016-2027
5.4 By Application - Global Biosimilar Monoclonal Antibodies Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Biosimilar Monoclonal Antibodies Market Size, 2021 & 2027
6.2 By Region - Global Biosimilar Monoclonal Antibodies Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Monoclonal Antibodies Revenue, 2016-2021
6.2.2 By Region - Global Biosimilar Monoclonal Antibodies Revenue, 2022-2027
6.2.3 By Region - Global Biosimilar Monoclonal Antibodies Revenue Market Share, 2016-2027
6.3 By Region - Global Biosimilar Monoclonal Antibodies Sales & Forecasts
6.3.1 By Region - Global Biosimilar Monoclonal Antibodies Sales, 2016-2021
6.3.2 By Region - Global Biosimilar Monoclonal Antibodies Sales, 2022-2027
6.3.3 By Region - Global Biosimilar Monoclonal Antibodies Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Biosimilar Monoclonal Antibodies Revenue, 2016-2027
6.4.2 By Country - North America Biosimilar Monoclonal Antibodies Sales, 2016-2027
6.4.3 US Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.4.4 Canada Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.4.5 Mexico Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Biosimilar Monoclonal Antibodies Revenue, 2016-2027
6.5.2 By Country - Europe Biosimilar Monoclonal Antibodies Sales, 2016-2027
6.5.3 Germany Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.5.4 France Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.5.5 U.K. Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.5.6 Italy Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.5.7 Russia Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.5.8 Nordic Countries Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.5.9 Benelux Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Biosimilar Monoclonal Antibodies Revenue, 2016-2027
6.6.2 By Region - Asia Biosimilar Monoclonal Antibodies Sales, 2016-2027
6.6.3 China Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.6.4 Japan Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.6.5 South Korea Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.6.6 Southeast Asia Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.6.7 India Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Biosimilar Monoclonal Antibodies Revenue, 2016-2027
6.7.2 By Country - South America Biosimilar Monoclonal Antibodies Sales, 2016-2027
6.7.3 Brazil Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.7.4 Argentina Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biosimilar Monoclonal Antibodies Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Biosimilar Monoclonal Antibodies Sales, 2016-2027
6.8.3 Turkey Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.8.4 Israel Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.8.5 Saudi Arabia Biosimilar Monoclonal Antibodies Market Size, 2016-2027
6.8.6 UAE Biosimilar Monoclonal Antibodies Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Celltrion
7.1.1 Celltrion Corporate Summary
7.1.2 Celltrion Business Overview
7.1.3 Celltrion Biosimilar Monoclonal Antibodies Major Product Offerings
7.1.4 Celltrion Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2016-2021)
7.1.5 Celltrion Key News
7.2 Pfizer (Hospira)
7.2.1 Pfizer (Hospira) Corporate Summary
7.2.2 Pfizer (Hospira) Business Overview
7.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Major Product Offerings
7.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2016-2021)
7.2.5 Pfizer (Hospira) Key News
7.3 3SBIO
7.3.1 3SBIO Corporate Summary
7.3.2 3SBIO Business Overview
7.3.3 3SBIO Biosimilar Monoclonal Antibodies Major Product Offerings
7.3.4 3SBIO Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2016-2021)
7.3.5 3SBIO Key News
7.4 Novartis (Sandoz)
7.4.1 Novartis (Sandoz) Corporate Summary
7.4.2 Novartis (Sandoz) Business Overview
7.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Major Product Offerings
7.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2016-2021)
7.4.5 Novartis (Sandoz) Key News
7.5 Dr Reddy’s
7.5.1 Dr Reddy’s Corporate Summary
7.5.2 Dr Reddy’s Business Overview
7.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Major Product Offerings
7.5.4 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2016-2021)
7.5.5 Dr Reddy’s Key News
7.6 Celgen Biopharma
7.6.1 Celgen Biopharma Corporate Summary
7.6.2 Celgen Biopharma Business Overview
7.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Major Product Offerings
7.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2016-2021)
7.6.5 Celgen Biopharma Key News
7.7 Cadila Healthcare
7.7.1 Cadila Healthcare Corporate Summary
7.7.2 Cadila Healthcare Business Overview
7.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Major Product Offerings
7.4.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2016-2021)
7.7.5 Cadila Healthcare Key News
7.8 Hisun Pharma
7.8.1 Hisun Pharma Corporate Summary
7.8.2 Hisun Pharma Business Overview
7.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Major Product Offerings
7.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2016-2021)
7.8.5 Hisun Pharma Key News
7.9 Torrent Pharmaceuticals
7.9.1 Torrent Pharmaceuticals Corporate Summary
7.9.2 Torrent Pharmaceuticals Business Overview
7.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Major Product Offerings
7.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales and Revenue in Global (2016-2021)
7.9.5 Torrent Pharmaceuticals Key News
8 Global Biosimilar Monoclonal Antibodies Production Capacity, Analysis
8.1 Global Biosimilar Monoclonal Antibodies Production Capacity, 2016-2027
8.2 Biosimilar Monoclonal Antibodies Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilar Monoclonal Antibodies Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilar Monoclonal Antibodies Supply Chain Analysis
10.1 Biosimilar Monoclonal Antibodies Industry Value Chain
10.2 Biosimilar Monoclonal Antibodies Upstream Market
10.3 Biosimilar Monoclonal Antibodies Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilar Monoclonal Antibodies Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com